Geron Corporation Logo Image

Geron Corporation

Most Recent Annual Report

2015 Annual Report and Form 10K

Geron Corporation

Geron Corporation does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

About Geron Corporation

51-200 Employees
Based in Menlo Park, California

Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection, as well as intends to develop products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring, and screening.

Ticker:
GERN
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol